The pharmaceutical industry is rapidly evolving, with growing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, stands as example of this trend. To fulfill this demand, US-based manufacturing services are stepping forward. These companies offer a wide-ranging suite of services, from researc